Senti,
I appreciate what you're saying and I could easily take my original investment out and still have lots of shares. I don't do it because I've asked myself, do I have a better place to invest the money? At this time my feeling is, no. I do have some diversification, and I believe there is great potential in others, but not as good as what I have right here.
Frankly when NWBO goes to anywhere close to double digits I expect Fidelity to tell me my portfolio is concentrated, then the choice may be to sell some and put the money into others or to take a little out of margin to add to the position in other stocks to eliminate the concentrated position. I'm frankly not certain which way I'll go then, I'll wait to see what I'm thinking then.
To me, the greatest potential for NWBO isn't in trials right now, I'm speaking of DCVax-Direct. If it's determined to work in many solid cancers I believe that over time it will be used before surgery, not just in inoperable tumors. DCVax-L might very well be made from the surgically removed tumor, so both can work together. My point is that GBM may just be the tip of the iceberg, it may be worth far more when we understand its full potential.
Gary
News 
Market Data 
Discover 
AI
